Protara Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-30.0M | $-28.5M | $-21.4M | $-3.3M | $-7.9M | $-8.0M |
| Depreciation & Amortization | — | $123.0K | $57.0K | $30.0K | $27.0K | $57.0K |
| Depreciation | $148.0K | $123.0K | $57.0K | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $3.2M | $3.3M | $2.2M | $459.0K | $155.0K | $110.0K |
| Net Cash from Operating Activities | $-22.4M | $-23.7M | $-17.6M | $-10.0M | $-6.7M | $-8.2M |
| Investing Activities | ||||||
| Capital Expenditures | $35.0K | $271.0K | $198.0K | $51.0K | $10.0K | $67.0K |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-16.1M | $19.9M | $-11.3M | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $23.0M | $208.0K | $163.0K | — | — | — |
| Net Change in Cash | $-15.2M | $-3.6M | $-28.8M | $66.0M | $384.0K | $-861.0K |
| Free Cash Flow | $-22.4M | $-24.0M | $-17.8M | $-10.0M | $-6.7M | $-8.3M |